<DOC>
	<DOCNO>NCT01745510</DOCNO>
	<brief_summary>- The purpose study determine whether docosahexaenoic acid effective prevention reduce severity necrotizing enterocolitis ( NEC ) preterm neonate &lt; 1500 g birth start enteral feeding . - NEC prevent , study measure whether hospital stay also reduce neonate receive Docosahexaenoic acid ( DHA )</brief_summary>
	<brief_title>Enteral Administration Docosahexaenoic Acid Prevent Necrotizing Enterocolitis Preterm Neonates</brief_title>
	<detailed_description>- Preterm neonate birth weight less 1500 g high risk develop NEC . - NEC inflammatory condition : 1 . Is medical urgency frequent gastrointestinal tube require neonatal intensive care 2. may perforate infant´s bowel require surgery 20 % 60 % case 3. may cause infant 's death 20 % 42 % case . 4. adequate treatment worldwide , therefore prevention need - DHA enteral feeding administrate research group attenuate inflammatory response septic surgical neonate . - Our result show : 1. low Interleukin ( IL ) -1 beta septic neonate , surgical neonate , also show less IL-6 anti-inflammatory cytokine IL-10 IL-1ra , adjust confounders 2. increase weight , length fat mass gain septic neonate 3. decrease organic failure surgical neonate , 4. low stay neonatal intensive care surgical neonate DHA use unique intervention high physiological dose ; addition , previous result find anti-inflammatory effect neonates.Therefore , expect preterm infant may reduce bowel inflammatory response lower NEC event severity</detailed_description>
	<mesh_term>Enterocolitis , Necrotizing</mesh_term>
	<mesh_term>Enterocolitis</mesh_term>
	<criteria>Birth weight low 1500 g Adequate weight gestational age Clinically stable begin enteral feed Written informed consent parent plus sign two witness Clinical biochemical data inflammatory response body core temperature alter , cardiac respiratory frequency low high accord age , leucocytosis leucopenia , take account threshold report Goldstein Pediatric Critical Care Medicine 2005 Vol 6 N°1 . Persistent bleed level Mother take n3 supplement plan breastfed Parents decline authorization participate study Early discharge hospital outside metropolitan area Persistent vomit Receiving medication avoid coagulation Gastrointestinal malformation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Weeks</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>docosahexaenoic acid</keyword>
	<keyword>n-3 fatty acid</keyword>
	<keyword>necrotizing enterocolitis</keyword>
	<keyword>preterm infant</keyword>
</DOC>